1. Home
  2. ALNT vs TBPH Comparison

ALNT vs TBPH Comparison

Compare ALNT & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALNT
  • TBPH
  • Stock Information
  • Founded
  • ALNT 1962
  • TBPH 2013
  • Country
  • ALNT United States
  • TBPH United States
  • Employees
  • ALNT N/A
  • TBPH N/A
  • Industry
  • ALNT Electrical Products
  • TBPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALNT Industrials
  • TBPH Health Care
  • Exchange
  • ALNT Nasdaq
  • TBPH Nasdaq
  • Market Cap
  • ALNT 777.2M
  • TBPH 699.0M
  • IPO Year
  • ALNT N/A
  • TBPH N/A
  • Fundamental
  • Price
  • ALNT $51.36
  • TBPH $17.35
  • Analyst Decision
  • ALNT Buy
  • TBPH Strong Buy
  • Analyst Count
  • ALNT 2
  • TBPH 4
  • Target Price
  • ALNT $47.50
  • TBPH $24.25
  • AVG Volume (30 Days)
  • ALNT 240.6K
  • TBPH 395.4K
  • Earning Date
  • ALNT 11-05-2025
  • TBPH 11-10-2025
  • Dividend Yield
  • ALNT 0.23%
  • TBPH N/A
  • EPS Growth
  • ALNT 28.52
  • TBPH N/A
  • EPS
  • ALNT 1.12
  • TBPH 0.58
  • Revenue
  • ALNT $533,134,000.00
  • TBPH $80,327,000.00
  • Revenue This Year
  • ALNT $3.47
  • TBPH $79.82
  • Revenue Next Year
  • ALNT $4.51
  • TBPH N/A
  • P/E Ratio
  • ALNT $47.46
  • TBPH $30.93
  • Revenue Growth
  • ALNT N/A
  • TBPH 27.12
  • 52 Week Low
  • ALNT $19.25
  • TBPH $7.90
  • 52 Week High
  • ALNT $58.13
  • TBPH $18.96
  • Technical
  • Relative Strength Index (RSI)
  • ALNT 50.44
  • TBPH 67.90
  • Support Level
  • ALNT $51.30
  • TBPH $14.51
  • Resistance Level
  • ALNT $55.01
  • TBPH $18.21
  • Average True Range (ATR)
  • ALNT 2.88
  • TBPH 0.83
  • MACD
  • ALNT -0.58
  • TBPH 0.35
  • Stochastic Oscillator
  • ALNT 53.69
  • TBPH 69.06

About ALNT Allient Inc.

Allient Inc, formerly Allied Motion Technologies Inc designs, manufactures, and sells precision and specialty motion control components and systems. The firm primarily caters to the vehicle, medical, aerospace and defense, and electronics and industrial, pumps, and robotics sectors. It mainly operates and sells across the United States, Canada, South America, Europe, and Asia. Its products and solutions include nano precision positioning systems, servo control systems, motion controllers, digital servo amplifiers and drives, brushless servo, torque, and coreless motors, brush motors, integrated motor drives, gear motors, gearing, incremental and absolute optical encoders, active (electronic) and passive (magnetic) filters for power quality and harmonic issues.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: